MX9300965A - Particulas marcadoras que alternan la gravedad especifica, que estan unidas a los componentes objetivo por anticuerpos especificos. - Google Patents

Particulas marcadoras que alternan la gravedad especifica, que estan unidas a los componentes objetivo por anticuerpos especificos.

Info

Publication number
MX9300965A
MX9300965A MX9300965A MX9300965A MX9300965A MX 9300965 A MX9300965 A MX 9300965A MX 9300965 A MX9300965 A MX 9300965A MX 9300965 A MX9300965 A MX 9300965A MX 9300965 A MX9300965 A MX 9300965A
Authority
MX
Mexico
Prior art keywords
target components
specific gravity
attached
alternate
marker particles
Prior art date
Application number
MX9300965A
Other languages
English (en)
Spanish (es)
Inventor
Judith Britz
Thomas J Mercolino
Robert A Levine
Stephen C Wardlaw
Rodolfo Rodriguez
Original Assignee
Robert A Levine
Stephen C Wardlaw
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert A Levine, Stephen C Wardlaw, Becton Dickinson Co filed Critical Robert A Levine
Publication of MX9300965A publication Critical patent/MX9300965A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/5375—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by changing the physical or chemical properties of the medium or immunochemicals, e.g. temperature, density, pH, partitioning
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
MX9300965A 1992-02-25 1993-02-23 Particulas marcadoras que alternan la gravedad especifica, que estan unidas a los componentes objetivo por anticuerpos especificos. MX9300965A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84197692A 1992-02-25 1992-02-25

Publications (1)

Publication Number Publication Date
MX9300965A true MX9300965A (es) 1994-08-31

Family

ID=25286232

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9300965A MX9300965A (es) 1992-02-25 1993-02-23 Particulas marcadoras que alternan la gravedad especifica, que estan unidas a los componentes objetivo por anticuerpos especificos.

Country Status (17)

Country Link
US (1) US5593848A (enExample)
EP (1) EP0557595B1 (enExample)
JP (1) JP2925105B2 (enExample)
CN (1) CN1091521A (enExample)
AT (1) ATE155889T1 (enExample)
AU (1) AU662571B2 (enExample)
BR (1) BR9300639A (enExample)
CA (1) CA2090282A1 (enExample)
DE (1) DE69221118T2 (enExample)
DK (1) DK0557595T3 (enExample)
ES (1) ES2106121T3 (enExample)
FI (1) FI930821L (enExample)
GR (1) GR3024970T3 (enExample)
MX (1) MX9300965A (enExample)
NO (1) NO930649L (enExample)
RU (1) RU2116068C1 (enExample)
TW (1) TW246716B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342790A (en) * 1992-10-30 1994-08-30 Becton Dickinson And Company Apparatus for indirect fluorescent assay of blood samples
AU4101697A (en) * 1996-11-22 1998-05-28 Robert A. Levine Process for enhancing the aggregation and/or agglutination of erythrocytes prior to centrifugation
US6197523B1 (en) 1997-11-24 2001-03-06 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood
AU9233698A (en) * 1997-11-22 1999-06-17 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer cells and/or hematologic progenitor cells in whole blood
US6911315B2 (en) * 1997-11-24 2005-06-28 David L. Rimm Method for the detection, identification, enumeration and confirmation of virally infected cells and other epitopically defined cells in whole blood
WO2000000507A1 (en) * 1998-06-26 2000-01-06 Pfizer Products Inc. Improved process for preparing schiff base adducts of amines with o-hydroxy aldehydes and compositions of matter based thereon
GB0021303D0 (en) * 2000-08-30 2000-10-18 Medinnova Sf Use
CA2504443A1 (en) * 2002-10-30 2004-05-13 Pointilliste, Inc. Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides
US20050112065A1 (en) * 2003-07-09 2005-05-26 Drummond Daryl C. Remote detection of substance delivery to cells
US7996825B2 (en) * 2003-10-31 2011-08-09 Hewlett-Packard Development Company, L.P. Cross-file inlining by using summaries and global worklist
WO2005067980A2 (en) * 2004-01-12 2005-07-28 Pointilliste, Inc. Design of therapeutics and therapeutics
WO2009124179A1 (en) 2008-04-02 2009-10-08 Abbott Point Of Care, Inc. Virtual separation of bound and free label in a ligand assay for performing immunoassays of biological fluids, including whole blood
WO2009126505A1 (en) * 2008-04-09 2009-10-15 Abbott Point Of Care, Inc. Method of detecting very low levels of analyte within a thin film fluid sample contained in a thin thickness chamber
FR2965273B1 (fr) * 2010-09-29 2015-07-17 Centre Nat Rech Scient Procede de preparation d'une structure chimique presentant une partition de phases, apte a generer un spectre de fluorescence specifique et ses applications
US9624474B2 (en) 2010-12-01 2017-04-18 Samsung Electronics Co, Ltd. Method of separating target cell in biological sample
CN102788879B (zh) * 2011-05-20 2015-04-01 常州康卫生物技术有限公司 一种生物检测试剂
AU2016258171B2 (en) * 2015-05-06 2021-12-09 LGC Clinical Diagnostics, Inc. Liposomal preparations for non-invasive-prenatal or cancer screening

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862303A (en) * 1972-02-02 1975-01-21 Atomic Energy Commission Method for rapid detection and identification of serological factors
US4027660A (en) * 1976-04-02 1977-06-07 Wardlaw Stephen C Material layer volume determination
US4181609A (en) * 1977-12-20 1980-01-01 Levine Robert A Blood constituents testing method
DE3000483A1 (de) * 1979-01-09 1980-07-17 Fuji Photo Film Co Ltd Mikrokapseln fuer immunologische bestimmungen
US4332785A (en) * 1980-04-09 1982-06-01 University Patents, Inc. Immunoassay for measurement of reticulocytes, and immunoreactive reagents for use therein
IL64878A (en) * 1982-01-27 1986-01-31 Yissum Res Dev Co Method for detection of and determination of malaria antibodies and malaria antigens in human blood
JPS5984162A (ja) * 1982-11-05 1984-05-15 Toshiba Corp 免疫分析法
US4591570A (en) * 1983-02-02 1986-05-27 Centocor, Inc. Matrix of antibody-coated spots for determination of antigens
JPS6035267A (ja) * 1983-08-05 1985-02-23 Fuji Photo Film Co Ltd 多項目免疫検査法
US5011771A (en) * 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
FR2571498B1 (fr) * 1984-10-04 1988-04-08 Immunotech Sa Procede de separation de cellules utilisant des anticorps et des billes de faible densite
JPS6345563A (ja) * 1986-04-11 1988-02-26 Hitachi Ltd 細胞分析方法
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
GB2200448B (en) * 1987-01-23 1991-01-16 Univ London Targetted liposomes and their use in immunoassay
US5017472A (en) * 1987-09-09 1991-05-21 Bankert Richard B Microflotation devices used for immunoassays and cell/molecular fractionation
US4978625A (en) * 1987-10-19 1990-12-18 Becton, Dickinson And Company Fluorescence immunoassay using water insoluble dyes
CA2033010A1 (en) * 1989-12-22 1991-06-23 Rajeev Ramanathan Method for separating components in a mixture
JPH03249561A (ja) * 1990-02-28 1991-11-07 Toshiba Corp 免疫分析試薬

Also Published As

Publication number Publication date
FI930821A7 (fi) 1993-08-26
ES2106121T3 (es) 1997-11-01
EP0557595B1 (en) 1997-07-23
BR9300639A (pt) 1993-08-31
ATE155889T1 (de) 1997-08-15
DK0557595T3 (da) 1997-12-29
EP0557595A3 (enExample) 1993-11-10
JP2925105B2 (ja) 1999-07-28
RU2116068C1 (ru) 1998-07-27
DE69221118T2 (de) 1998-02-26
GR3024970T3 (en) 1998-01-30
FI930821A0 (fi) 1993-02-24
NO930649D0 (no) 1993-02-24
FI930821L (fi) 1993-08-26
AU662571B2 (en) 1995-09-07
TW246716B (enExample) 1995-05-01
DE69221118D1 (de) 1997-09-04
AU2983692A (en) 1993-08-26
US5593848A (en) 1997-01-14
CA2090282A1 (en) 1993-08-26
EP0557595A2 (en) 1993-09-01
JPH0821833A (ja) 1996-01-23
NO930649L (no) 1993-08-26
CN1091521A (zh) 1994-08-31

Similar Documents

Publication Publication Date Title
ES2040682T1 (es) Un procedimiento para la preparacion de un compuesto de dioxetano.
ES8407592A1 (es) Un dispositivo para seleccionar celulas biologicas particulares y metodo correspondiente.
ES2140870T3 (es) Deteccion de potenciales transmembrana por metodos opticos.
DK1000345T3 (da) Fremgangsmåde og apparat til dannelse af referencer for fluorescensintensitetssignaler
ES2185623T3 (es) Pruebas aloantigenicas mediante ensayo de union.
DK1029233T3 (da) Måling af koncentrationen af et stof
ES2106121T3 (es) Ensayo de componentes diana.
DE3788230D1 (de) Vorrichtung zur Messung der Fluoreszenz-Abklingdauer einer fluoreszierenden Substanz.
IT8121570A0 (it) Tubo acceleratore di neutroni avente una sezione bersaglio perfezionata.
RU93004564A (ru) Модифицирующая удельный вес маркерная частица, способ анализа пробы биологической жидкости, применение маркерной частицы в анализе пробы биологической жидкости
CN206684041U (zh) 一种共聚焦低杂光荧光检测光学系统
MX166055B (es) Procedimiento para determinar la presencia de un producto analizado en una muestra que se sospecha que contiene el producto analizado
SE8008374L (sv) Anordning for provtagning av en genom en rorledning strommande suspension, i synnerhet fibersuspension
ATA280181A (de) Vorrichtung zur optischen scharfeinstellung
SE7613894L (sv) Sett och apparat for vattenanalys
CY1110429T1 (el) Προσδιορισμος
US6335997B1 (en) Device and method for attenuating a low-level light source over a very wide dynamic range
NL181309B (nl) Zonder lamp werkzame optische indicator.
ES2147731T3 (es) Haptenos, trazadores, inmunogenos y anticuerpos para inmunoanalisis de deteccion de propoxifeno.
ES2160783T3 (es) Metodos para detectar parvovirus humano.
Strutt et al. The Becquerel rays and the properties of radium
DE69713138D1 (de) Immuntestsystem zur bestimmung von vitamin d
DE69102501D1 (de) Fluoreszente Zusammensetzung für Elektronenstrahlanregung mit niedriger Geschwindigkeit.
JPS51129288A (en) Sample cell for fluorescence detector
DE69026008D1 (de) Gerät zur Beschaffung von Abstandsinformation von einem Objekt, mittels augenblicklicher Beleuchtung des Objekts durch einen Lichtstrahl